[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:lung-neuroendocrine-tumor-g2":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":16,"states":17},"Lung Neuroendocrine Tumor G2",1,0,[8],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05557708","A Safety Study of 212Pb-Pentixather Radioligand Therapy",[12],"Early Phase 1","NOT_YET_RECRUITING","2026-08-26T02:17:18.747857Z","2026-05-05T02:43:26.937880Z",[],[]]